慢性肾脏病患者的视力损害与主要眼病:2005-2008年美国国家健康与营养调查
该横断面研究基于2005-2008年美国国家健康与营养调查中5518名40岁及以上参与者,评估慢性肾脏病(CKD)与视力损害(VI)及主要眼病的患病率和关联。结果显示CKD患者VI和主要眼病患病率约为非CKD者的2-7倍,校正混杂因素后CKD与VI、任何眼病、任何客观确定的眼病、任何视网膜病变及糖尿病视网膜病变(DR)显著相关,但与白内障手术、年龄相关性黄斑变性(AMD)或青光眼无关联。
要点
- CKD患者视力损害和主要眼病患病率显著高于非CKD者。
- 校正混杂因素后,CKD与视力损害、任何眼病、视网膜病变及DR独立相关。
- CKD与白内障手术、AMD或青光眼无显著关联。
核心结论
- CKD与视力损害及主要眼病存在高患病率和强关联,提示CKD患者应重视眼部筛查。
研究设计与样本
- 横断面研究,纳入2005-2008年美国国家健康与营养调查中5518名40岁及以上参与者。
- CKD定义为估算肾小球滤过率低于60 mL/min/1.73 m2。
- 视力损害定义为较好眼矫正视力差于20/40。
主要发现
- CKD患者视力损害和主要眼病患病率约为非CKD者的2至7倍(所有P < .05)。
- 校正多因素后,CKD与视力损害相关(OR: 2.01,95%CI: 1.14-3.54)。
- CKD与任何眼病相关(OR: 1.65,95%CI: 1.22-2.22),与任何客观确定的眼病相关(OR: 1.52,95%CI: 1.06-2.19)。
- CKD与任何视网膜病变相关(OR: 1.70,95%CI: 1.18-2.45),与糖尿病视网膜病变相关(OR: 2.34,95%CI: 1.23-4.42)。
- CKD与白内障手术、年龄相关性黄斑变性或青光眼无关联。
关键数值与推荐
- CKD定义为估算肾小球滤过率低于60 mL/min/1.73 m2。
- 视力损害定义为较好眼矫正视力差于20/40。
- 主要眼病通过问卷或视网膜照片采用标准化分级方案评估。
临床怎么用
- CKD患者应进行眼部筛查以早期发现视力损害和视网膜病变。
- 对CKD患者应关注糖尿病视网膜病变和任何视网膜病变的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the prevalence and associations of visual impairment (VI) and major eye diseases with chronic kidney disease (CKD) in the United States. DESIGN: Cross-sectional study. METHODS: We investigated the prevalence and associations of VI and major eye diseases with CKD among 5,518 participants aged 40 years or older in the 2005-2008 National Health and Nutrition Examination Survey. An estimated glomerular filtration rate of lower than 60 mL/min/1.73 m2 was defined as CKD. Corrected visual acuity of worse than 20/40 in the better-seeing eye was defined as VI. Major eye diseases, including any ocular disease, any objectively determined ocular disease, cataract surgery, any retinopathy, diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma were evaluated from questionnaire or retinal photographs using standardized grading protocols. RESULTS: The prevalence of VI and major eye diseases were approximately 2- to 7-fold higher in participants with CKD than in those without (all P < .05). After controlling for multiple confounders, the presence of CKD was associated with VI (odds ratio [OR]: 2.01, 95% confidence interval [CI]: 1.14-3.54), any ocular disease (OR: 1.65, 95% CI: 1.22-2.22), any objectively determined ocular disease (OR: 1.52, 95% CI: 1.06-2.19), any retinopathy (OR: 1.70, 95% CI: 1.18-2.45), and DR (OR: 2.34, 95% CI: 1.23-4.42). There was no association of CKD with cataract surgery, AMD, or glaucoma. A significant association between CKD and any ocular disease was observed among nondiabetic participants. The presence of CKD was closely related to VI and any retinopathy among diabetic participants. CONCLUSIONS: This nationally representative sample of the US population demonstrated high prevalence and strong associations of VI and major eye diseases with CKD, highlighting the importance of ocular screening among CKD patients and potential common pathogenesis underlying these conditions.
引用
- Zhu Z, Liao H, Wang W, et al. Visual Impairment and Major Eye Diseases in Chronic Kidney Disease: The National Health and Nutrition Examination Survey, 2005-2008. Am J Ophthalmol. 2020. PMID: 31945332. doi:10.1016/j.ajo.2020.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。